{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:14:11Z","timestamp":1782846851861,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":123,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinsp.2024.100387","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:58:40Z","timestamp":1716803920000},"page":"100387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical research of fibroscan \u2012 TE-CAP at noninvasive diagnosis of hepatic steatosis in children"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0181-8458","authenticated-orcid":false,"given":"Shuangzhen","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5549-5145","authenticated-orcid":false,"given":"Jianli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1712-1073","authenticated-orcid":false,"given":"Qiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7178-5877","authenticated-orcid":false,"given":"Shaoming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6904-575X","authenticated-orcid":false,"given":"Zhaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6750-8583","authenticated-orcid":false,"given":"Xiaolin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4858-475X","authenticated-orcid":false,"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clinsp.2024.100387_bib0001","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.cgh.2022.02.008","article-title":"Nonalcoholic fatty liver disease in children: where are we?","volume":"20","author":"Li","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100387_bib0002","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.01.048","article-title":"Nonalcoholic Fatty Liver Disease in Children: unique Considerations and Challenges","volume":"158","author":"Goldner","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100387_bib0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.clinsp.2024.100387_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"Global NAFLD Prevalence: a Systematic Review and Meta-analysis","volume":"20","author":"Le","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100387_bib0005","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100387_bib0006","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2021.01.004","article-title":"MAFLD: A game changer redefining fatty liver disease for adults and children","volume":"74","author":"Eslam","year":"2021","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.clinsp.2024.100387_bib0007","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement","volume":"6","author":"Eslam","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100387_bib0008","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100387_bib0009","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100387_bib0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.sult.2016.08.003","article-title":"Hepatic Steatosis: etiology, Patterns, and Quantification","volume":"37","author":"Idilman","year":"2016","journal-title":"Semin Ultrasound CT MR"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100387_bib0011","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100387_bib0012","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100387_bib0013","article-title":"Non-alcoholic fatty liver disease: a patient guideline","volume":"3","author":"Francque","year":"2021","journal-title":"JHEP Rep"},{"issue":"11","key":"10.1016\/j.clinsp.2024.100387_bib0014","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"56","author":"Tokushige","year":"2021","journal-title":"J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100387_bib0015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an Endpoint in NASH Trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100387_bib0016","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","article-title":"Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis","volume":"6","author":"Petroff","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"38","key":"10.1016\/j.clinsp.2024.100387_bib0017","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","article-title":"Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): current Concepts","volume":"24","author":"Papatheodoridi","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100387_bib0018","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00330-020-07245-2","article-title":"Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity","volume":"31","author":"Runge","year":"2021","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100387_bib0019","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12887-019-1485-8","article-title":"Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard","volume":"19","author":"Shin","year":"2019","journal-title":"BMC Pediatr"},{"issue":"23","key":"10.1016\/j.clinsp.2024.100387_bib0020","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.3346\/jkms.2019.34.e165","article-title":"Usefulness of transient elastography for non-invasive diagnosis of liver fibrosis in pediatric non-alcoholic steatohepatitis","volume":"34","author":"Kwon","year":"2019","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clinsp.2024.100387_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.784221","article-title":"Magnetic resonance imaging-proton density fat fraction vs. transient elastography-controlled attenuation parameter in diagnosing non-alcoholic fatty liver disease in children and adolescents: a meta-analysis of diagnostic accuracy","volume":"9","author":"Jia","year":"2022","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100387_bib0022","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2020.03.020","article-title":"Accurate diagnosis of NAFLD-related hepatic fibrosis with non-invasive methods: a comment for moving forward","volume":"73","author":"Li","year":"2020","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.clinsp.2024.100387_bib0023","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.clinsp.2024.100387_bib0024","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3748\/wjg.v25.i12.1513","article-title":"Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents","volume":"25","author":"Zhao","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100387_bib0025","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.29596","article-title":"Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease","volume":"67","author":"Middleton","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clinsp.2024.100387_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"51","author":"Cao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.clinsp.2024.100387_bib0027","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fped.2019.00518","article-title":"Metagenome of gut microbiota of children with nonalcoholic fatty liver disease","volume":"7","author":"Zhao","year":"2019","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100387_bib0028","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.clinsp.2024.100387_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.11.060","article-title":"Prospective, Same-day, direct comparison of controlled attenuation parameter with the M vs. the XL probe in patients with nonalcoholic fatty liver disease, using magnetic resonance imaging-proton density fat fraction as the standard","volume":"18","author":"Caussy","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100387_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12098-021-03842-1","article-title":"Usefulness of controlled attenuation parameter for identification and grading of nonalcoholic fatty liver disease in adolescents with obesity","volume":"89","author":"Anand","year":"2022","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.clinsp.2024.100387_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.03.021","article-title":"Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients","volume":"173","author":"Desai","year":"2016","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100387_bib0032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12876-017-0617-6","article-title":"Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter","volume":"17","author":"Ferraioli","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinsp.2024.100387_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1030809","article-title":"Pediatric percentiles for transient elastography measurements - effects of age, sex, weight status and pubertal stage","volume":"13","author":"Brunnert","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100387_bib0034","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41390-021-01441-6","article-title":"Defining values for controlled attenuation parameter and liver stiffness in youth without liver disease","volume":"91","author":"Ram\u00edrez-V\u00e9lez","year":"2022","journal-title":"Pediatr Res"},{"issue":"11","key":"10.1016\/j.clinsp.2024.100387_bib0035","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/hep4.1983","article-title":"The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in children","volume":"6","author":"Chaidez","year":"2022","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100387_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101755","article-title":"Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease","volume":"46","author":"Chen","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T04:23:28Z","timestamp":1735791808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593224000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":36,"alternative-id":["S1807593224000644"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100387","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical research of fibroscan \u2012 TE-CAP at noninvasive diagnosis of hepatic steatosis in children","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100387"}}